IL10 and campylobacteriosis: These mice were successfully used to study the immunopathological response against defined C. jejuni virulence factors during disease initiation and progression.128–131 Moreover, further standardization of C. jejuni infection in SAB IL-10-deficient mice allowed for preclinical studies testing the efficacy of drugs affecting the innate immune response against campylobacteriosis.109